P255 : Clinical and histological effects of topical epidermal growth factor on acne and acne scar
분야
의약학 > 피부과학
저자
( Dong Hyo Kim ) , ( Ji Hoon Yang ) , ( Soo Ick Cho ) , ( Ji Young Yoon ) , ( Ji Won Kim ) , ( Sungjun Choi ) , ( Dae Hun Suh )
발행기관
대한피부과학회
간행물정보
프로그램북(구 초록집) 2020년, 제72권 제2호, 491(총1페이지)
파일형식
27739501.pdf [무료 PDF 뷰어 다운로드]
  • ※ 본 자료는 참고용 논문으로 수정 및 텍스트 복사가 되지 않습니다.
  • 구매가격
    0원
    적립금
    0원 (구매자료 3% 적립)
    이메일 발송  스크랩 하기
    자료 다운로드  네이버 로그인
    영문초록
    Background: Acne is a chronic skin disorder, and its inflammatory lesions leave scars which greatly affects the quality of life of patients. Currently, treatment options targeting both acne and acne scars are still lacking.
    Objectives: To evaluate clinical efficacy of topical epidermal growth factor ointment (EGFO) on acne lesions and scars.
    Methods: The study design was 12-week, prospective, split-face, non-blind. The 36 adult patients with mild to moderate acne vulgaris applied EGFO on one side of the face and vehicle ointment on the other side twice daily. Patients were assessed every 4 weeks by acne lesion and scar counts, investigator’s global assessment for acne (IGA) and scar (SGA), and ECCA scar grading scale. Skin biopsies were performed before and after treatment.
    Results: The severity of acne and acne scars were significantly improved in EGFO-treated sides, while control sides were not. Acne lesion and scar counts were significantly reduced after 4 weeks, while IGA, SGA, and ECCA grades significantly decreased after 8 weeks. Immunohistochemistry showed decreased expression of keratin 16, NFkBp65, IL-1α in acne lesions, and increased expression of elastin, collagen type 1, 3 in acne scars after treatment.
    Conclusion: EGFO can be a treatment option for acne and acne scar.
    사업자등록번호 220-87-87785 대표.신현웅 주소.서울시 서초구 방배로10길 18, 402호 대표전화.070-8809-9397
    개인정보책임자.박정아 통신판매업신고번호 제2017-서울서초-1765호 이메일 help@reportshop.co.kr
    copyright (c) 2009 happynlife. steel All reserved.